News

Walkable communities could aid in reduction of type 2 diabetes.

The report examined the most common contact lens searches via Google auto-complete results, 65% of which were reported as purchase driven.

Catch up on the top stories in optometry during the week of June 16-June 20.

A recent $1 million gift will aid in broadening access to emotional support services, including social workers, peer connections, and multimedia content include videos and podcasts.

The Ontario Health Coalition has gathered evidence such as proof of payment and patient reports from 50 patients for the formal complaint.

Priya S. Vakharia, MD; and Deepak Sambhara, MD, FASRS, provide tips to ensure effective comanagement between retina specialists, optometrists, and ophthalmologists.

A study reveals a genetic link between instant coffee consumption and increased risk of dry age-related macular degeneration, urging caution for high-risk individuals.

The report categorizes research into 7 categories: sex, gender, and hormones; epidemiology; pathophysiology; tear film; pain and sensation; iatrogenic; and clinical trial design.

The 128th AOA Congress and 57th AOSA conference will be held in Minneapolis, Minnesota, and will feature a wide variety of symposia, CE, and special events for optometrists, residents, and students.

Maggie Cline, MPH, initially joined the organization in 2022 and served as Executive Director Utah.

This year's meeting is taking place from June 25-28 in Minneapolis, Minnesota.

Aldeyra resubmits NDA for reproxalap, aiming to address FDA concerns and demonstrate efficacy in treating dry eye disease symptoms.

ZinserLab will focus on accelerating the development of imaging technologies in eye care.

The Encompass platform works to integrate with other third-party applications for cloud-based practice management and electronic health records software solutions.

Jeffrey Anshel, OD, FAAO, outlines integrating nutritional supplements into patient eye care.

Catch up on the top stories in optometry during the week of June 9-June 13.

This new QLS-111 and latanoprost fixed-dose combination (QLS-111-FDC; Qlaris) is in development for the treatment of primary open-angle glaucoma, ocular hypertension, and normal-tension glaucoma in patients whose optimal intraocular pressure control may remain “unachievable” due to needing to lower episcleral venous pressure.

Anthem will also be required to conduct quarterly self-audits beginning in July of this year in order to document the correction of the issues stated in the report.

Presenters from the Collaborative Care Symposium 2025 give their key takeaways from their presentations.

The generic formulation references Pred Forte, which is trademarked by Allergan.

The report highlights clinical successes, innovation, research, and patient outcomes.

The Vision Lab Choice Act of 2025, S 1716 was introduced to the US Senate floor on May 12.

Incorporating peripheral OCTs into your practice provides valuable insights that may alter your clinical diagnosis.

Researchers hypothesize that lamivudine was effective in the clinical trial against DME because the drug blocks the activity of inflammasomes.

Bryce St Clair, OD, MPH, authors the June edition of the Cultural Responsiveness Blog, and urges doctors to consider cultural and socioeconomic backgrounds when caring for patients.

The ophthalmology platform Optegra operates more than 70 eye hospitals and diagnostic facilities in 5 European markets.